Insulet's maiden buy expands diabetes offering and grows customer base over three-fold
This article was originally published in Clinica
Executive Summary
Marking its first acquisition since it went public in 2007, Insulet has bought Neighborhood Diabetes, a US distributor of diabetes supplies, for $63m. The move not only significantly expands Insulet's customer base in the US, increasing it from around 25,000 to 85,000, it also broadens the company's current offering beyond its flagship product, the OmniPod insulin pump, and consolidates its position in the diabetes market.